Possible reasons for today�s excellent performance:
1. Mr. Schenck has only been hired a few weeks and may be having success at showing investors the rich Biotechnology pipeline at AMRI. "P. Curtis Schenck has joined the company as manager of investor relations. He will represent AMRI with securities analysts as well as institutional and retail investors."
2. With the recent Pfizer patent success Dr. D�Ambra�s process and patent look even more secure. 3. GE renewing and expanding demand for one of it�s products. 4. Biotechnology funding has increased so expect AMRI to be full, full, full! No matter how many hours AMRI�s dedicated scientists work, my bet is they can�t keep up with demand. 5. News may be coming that one of the 10 Phase compounds is to go commercial.